AGENT FOR TREATMENT OF DRY EYE CHARACTERIZED BY COMBINING P2Y² RECEPTOR AGONIST WITH HYALURONIC ACID OR SALT THEREOF, METHOD FOR TREATING DRY EYE, AND USE OF THE P2Y² RECEPTOR AGONIST AND HYALURONIC ACID OR SALT THEREOF
An agent for treatment of dry eye comprising a combination of a P2Y2 receptor agonist at a therapeutically effective concentration and hyaluronic acid or a salt thereof at a therapeutically effective concentration, which agent has a dosage form of an ophthalmic agent, can promote the secretion of tear remarkably and can improve corneal epithelial disorders remarkably, and is therefore expected to be a novel agent for treatment of dry eye.
